Neurological Outcomes of Primary Intracerebral Haemorrhage (HIP-REA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03995940|
Recruitment Status : Recruiting
First Posted : June 24, 2019
Last Update Posted : June 24, 2019
|Condition or disease|
|Intracranial Hemorrhage, Hypertensive|
ICH represent a diagnostic and therapeutic emergency. ICH account for 20% of strokes with a one-year mortality of more than 45% and an uncertain neurological outcome.
For ICH patients, the main initial challenge is to determine the long term neurological outcomes and adapt the therapeutic strategy.
The majority of primary and spontaneous ICH studies involve patients in stroke units.
The study is an observational type 3 research with all the patients admitted in all the University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for a primary and spontaneous supratentorial ICH
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Neurological Outcomes of Primary Intracerebral Haemorrhage Admitted in Intensive Care Unit at the University Hospital of Grenoble Alpes|
|Actual Study Start Date :||April 30, 2019|
|Estimated Primary Completion Date :||November 2019|
|Estimated Study Completion Date :||January 2020|
- Neurological outcomes [ Time Frame: One year after the stroke ]Collection of the Modified Ranking Scale (mRS) at one year by patients phone call or with the medicale file.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03995940
|Contact: Catherine Portalemail@example.com|
|Contact: Camille Ducki||ArcPromoteur@chu-grenoble.fr|
|Grenoble University Hospital||Recruiting|
|Grenoble, France, 38000|
|Contact: Pierluigi Banco, MD +184.108.40.206.67.29 firstname.lastname@example.org|
|Principal Investigator: Pierluigi Banco, MD|
|Sub-Investigator: Samuel Bersinger, MD|